The role involves designing and executing Phase 2/3 studies in the Neuroscience Late Development portfolio while ensuring patient safety through rigorous medical data reviews.
Base: $199,000.00 - $343,850.00; Bonus/Equity: Eligible for long-term incentive program; Benefits: Includes 401(k), pension, vacation, sick time, and parental leave
Must-have
Nice-to-have
Not specified